Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Parkman Healthcare Partners LLC
Form 13F · Q2 2026

Parkman Healthcare Partners LLC

CIK 1777015Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$977M
Reported book value
77
Positions
12
Quarters on record
Top 50
Positions

Parkman Healthcare Partners LLC — holdings

Top 50 positions of 77, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1MBX Mbx Biosciences Inc800,173+0.0%$44M4.5%
2LLY Eli Lilly & Co35,000+1.1%$42M4.3%
3CVS Cvs Health Corp391,791+1.2%$41M4.1%
4DXCM Dexcom Inc534,767−22.5%$36M3.7%
5PTCT Ptc Therapeutics Inc435,691+1.0%$36M3.6%
6RCUS Arcus Biosciences Inc919,266−23.9%$28M2.9%
7GPCR Structure Therapeutics Inc485,661+109.3%$26M2.7%
8VRDN Viridian Therapeutics Inc1.4M+146.9%$25M2.6%
9AGIO Agios Pharmaceuticals Inc669,046+65.8%$25M2.5%
10INBX Inhibrx Biosciences Inc256,950—$24M2.5%
11XENE Xenon Pharmaceuticals Inc397,379−20.1%$24M2.5%
12EWTX Edgewise Therapeutics Inc577,036+78.7%$23M2.4%
13UNH Unitedhealth Group Inc55,921—$23M2.4%
14SYK Stryker Corporation67,973−56.1%$21M2.2%
15IQV Iqvia Hldgs Inc105,811+22.0%$20M2.1%
16ZBH Zimmer Biomet Holdings Inc232,557−13.7%$20M2.0%
17PODD Insulet Corp131,378−16.1%$20M2.0%
18ASMB Assembly Biosciences Inc721,181+75.4%$20M2.0%
19SNDX Syndax Pharmaceuticals Inc877,256−2.7%$19M2.0%
20EYPT Eyepoint Inc1.3M−4.9%$18M1.9%
21THC Tenet Healthcare Corp97,280+94.1%$18M1.9%
22LIVN Livanova Plc210,529−47.9%$17M1.8%
23ANIP Ani Pharmaceuticals Inc202,907−27.7%$17M1.7%
24BCRX Biocryst Pharmaceuticals Inc1.6M−4.9%$16M1.7%
25ALNY Alnylam Pharmaceuticals Inc50,672+88.3%$15M1.6%
26INDIVIOR PHARMACEUTICALS INC Indivior Pharmaceuticals Inc364,269—$15M1.5%
27NVST Envista Holdings Corporation553,916−22.2%$15M1.5%
28DRUG Bright Minds Biosciences Inc205,053+411.4%$14M1.5%
29XERS Xeris Biopharma Holdings Inc1.8M+5.0%$14M1.5%
30AVTX Avalo Therapeutics Inc766,290—$14M1.4%
31FDMT 4D Molecular Therapeutics In948,184+81.4%$13M1.3%
32IMNM Immunome Inc594,202+47.3%$13M1.3%
33STOK Stoke Therapeutics Inc355,443+5.6%$12M1.2%
34WATERS CORP Waters Corp30,206+14.2%$11M1.2%
35ANRO Alto Neuroscience Inc429,035—$11M1.2%
36ORKA Oruka Therapeutics Inc113,188—$11M1.1%
37ADPT Adaptive Biotechnologies Cor486,984−11.7%$10M1.1%
38ABSI Absci Corporation894,374−52.0%$10M1.1%
39MLYS Mineralys Therapeutics Inc380,354+0.1%$10M1.1%
40COGT Cogent Biosciences Inc253,365+153.0%$10M1.0%
41UNIQURE NV Uniqure Nv208,170+0.6%$10M1.0%
42TARS Tarsus Pharmaceuticals Inc150,000—$9M1.0%
43AMRX Amneal Pharmaceuticals Inc541,190+79.9%$9M1.0%
44IRTC Irhythm Holdings Inc67,267+67.6%$8M0.8%
45CYRX Cryoport Inc508,324—$8M0.8%
46BSX Boston Scientific Corp180,481−59.8%$8M0.8%
47CLYM Climb Bio Inc563,484—$7M0.8%
48AMLX Amylyx Pharmaceuticals Inc398,782−35.8%$7M0.7%
49UPB Upstream Bio Inc935,247+18.9%$6M0.7%
50RMD Resmed Inc32,983—$6M0.7%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.